Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127460253 | 12746025 | 3 | F | 20160921 | 20160915 | 20160924 | PER | US-GLAXOSMITHKLINE-US2016GSK134515 | GLAXOSMITHKLINE | 0.00 | F | Y | 86.00000 | KG | 20160924 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127460253 | 12746025 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | UNK | 20241 | |||||||||||
| 127460253 | 12746025 | 2 | SS | APTIOM | ESLICARBAZEPINE ACETATE | 1 | Oral | UNK, U | 0 | TABLET | |||||||||
| 127460253 | 12746025 | 3 | SS | DILANTIN | PHENYTOIN | 1 | UNK | 0 | |||||||||||
| 127460253 | 12746025 | 4 | C | KEPPRA | LEVETIRACETAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127460253 | 12746025 | 1 | Seizure |
| 127460253 | 12746025 | 2 | Epilepsy |
| 127460253 | 12746025 | 3 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127460253 | 12746025 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127460253 | 12746025 | Drug ineffective | |
| 127460253 | 12746025 | Seizure | |
| 127460253 | 12746025 | Vagal nerve stimulator implantation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |